Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 20531208)

Published in J Acquir Immune Defic Syndr on October 01, 2010

Authors

Setor Kunutsor1, Morgan Evans, Janine Thoulass, John Walley, Elly Katabira, James N Newell, Simon Muchuro, Hudson Balidawa, Elizabeth Namagala, Eric Ikoona

Author Affiliations

1: Nuffield Centre for International Health and Development, Institute of Health Sciences, Leeds University, Leeds, UK. skk31@cantab.net

Articles citing this

Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med (2014) 1.69

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS One (2014) 1.14

Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging (2013) 1.11

Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention. J Acquir Immune Defic Syndr (2013) 1.11

Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study. AIDS Res Treat (2010) 1.02

Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India. PLoS One (2013) 1.02

Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania. Malar J (2014) 0.91

Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health (2016) 0.78

Development of an electronic medical record based alert for risk of HIV treatment failure in a low-resource setting. PLoS One (2014) 0.76

Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa. AIDS (2017) 0.75

Articles by these authors

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84

The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48

HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 3.78

Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One (2009) 3.66

Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One (2011) 3.27

Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis (2003) 3.07

A call to action for comprehensive HIV services for men who have sex with men. Lancet (2012) 2.70

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med (2013) 2.44

Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? Lancet (2008) 2.31

Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis (2013) 2.18

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS (2013) 2.17

Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health (2012) 2.08

Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda. AIDS Behav (2006) 2.08

Causes of stigma and discrimination associated with tuberculosis in Nepal: a qualitative study. BMC Public Health (2007) 2.05

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther (2006) 2.02

Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav (2012) 2.01

Delayed consultation among pulmonary tuberculosis patients: a cross sectional study of 10 DOTS districts of Ethiopia. BMC Public Health (2009) 1.92

How to get research into practice: first get practice into research. Bull World Health Organ (2007) 1.85

Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry (2010) 1.73

Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study. AIDS Behav (2010) 1.69

Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol (2014) 1.66

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64

Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry (2006) 1.62

Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health (2004) 1.60

Barriers to TB care for rural-to-urban migrant TB patients in Shanghai: a qualitative study. Trop Med Int Health (2009) 1.53

Developing independent investigators for clinical research relevant for Africa. Health Res Policy Syst (2011) 1.39

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr (2008) 1.37

Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol (2007) 1.35

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One (2012) 1.33

Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr (2011) 1.26

Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland. BMC Health Serv Res (2010) 1.26

The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. Afr Health Sci (2008) 1.25

Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial. AIDS Behav (2011) 1.24

Quality of tuberculosis care and its association with patient adherence to treatment in eight Ethiopian districts. Health Policy Plan (2009) 1.18

Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr (2012) 1.17

Improving tuberculosis care in low income countries - a qualitative study of patients' understanding of "patient support" in Nepal. BMC Public Health (2009) 1.16

Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: an intervention study. Infect Dis Poverty (2012) 1.15

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial. AIDS (2010) 1.15

Costs of a successful public-private partnership for TB control in an urban setting in Nepal. BMC Public Health (2007) 1.13

Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors. J Acquir Immune Defic Syndr (2007) 1.13

Listening to those on the frontline: lessons for community-based tuberculosis programmes from a qualitative study in Swaziland. Soc Sci Med (2005) 1.13

Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience. J Acquir Immune Defic Syndr (2014) 1.11

Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in Uganda. Afr Health Sci (2007) 1.11

Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr (2014) 1.09

Comparing patient care seeking pathways in three models of hospital and TB programme collaboration in China. BMC Infect Dis (2013) 1.08

Government-NGO collaboration: the case of tuberculosis control in Bangladesh. Health Policy Plan (2006) 1.08

The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe. BMC Health Serv Res (2014) 1.08

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clin Infect Dis (2012) 1.07

Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda. PLoS One (2011) 1.06

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda. Hum Resour Health (2009) 1.05

Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia. BMC Public Health (2010) 1.05

Research into practice: 10 years of international public health partnership between the UK and Swaziland. J Public Health (Oxf) (2010) 1.04

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. J Antimicrob Chemother (2012) 1.04

Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA (2004) 1.04

Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. Am J Epidemiol (2013) 1.04

A systematic review of current knowledge of HIV epidemiology and of sexual behaviour in Nepal. Trop Med Int Health (2002) 1.03

Clinic Attendance for Medication Refills and Medication Adherence amongst an Antiretroviral Treatment Cohort in Uganda: A Prospective Study. AIDS Res Treat (2010) 1.02

Early-onset versus late-onset HIV-related secondary mania in Uganda. Psychosomatics (2009) 0.99

Introduction and evaluation of a 'pre-ART care' service in Swaziland: an operational research study. BMJ Open (2012) 0.99

An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr (2014) 0.98

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda. AIDS Res Ther (2009) 0.98

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria. PLoS One (2013) 0.97

Integrating intensified case finding of tuberculosis into HIV care: an evaluation from rural Swaziland. BMC Health Serv Res (2011) 0.97

Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr (2004) 0.96

Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda. Trop Med Int Health (2012) 0.96

Validation of the Missoula-Vitas Quality-of-Life Index among patients with advanced AIDS in urban Kampala, Uganda. J Pain Symptom Manage (2007) 0.95

Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial. Ann Intern Med (2013) 0.95

Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults. J Antimicrob Chemother (2012) 0.94

First-line antiretroviral therapy in Africa--how evidence-base are our recommendations? AIDS Rev (2005) 0.94

Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda. AIDS Behav (2010) 0.93

The Infectious Diseases Institute at Makerere University, Kampala, Uganda. Infect Dis Clin North Am (2011) 0.92

Comparing knowledge and use of health services of migrants from rural and urban areas in Kunming City, China. J Biosoc Sci (2010) 0.92

Characteristics of high risk people with cardiovascular disease in Chinese rural areas: clinical indictors, disease patterns and drug treatment. PLoS One (2013) 0.91

Getting research into practice: primary care management of noncommunicable diseases in low- and middle-income countries. Bull World Health Organ (2012) 0.91

Validation in Uganda of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings. J Acquir Immune Defic Syndr (2011) 0.91

HIV/AIDS. Universal access in the fight against HIV/AIDS. Science (2010) 0.91